SAB Biotherapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2025, with ―. This bring the company's revenue in the last twelve months to -410.00, Increased -100.16%. In the fiscal year ending Dec 31, 2024, SAB Biotherapeutics had annual revenue of 1.32M with -40.96% growth.